NCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
Blokhin's Russian Cancer Research Center
The First Affiliated Hospital of Soochow University
Institute of Hematology & Blood Diseases Hospital, China
Women's Hospital School Of Medicine Zhejiang University
Nanfang Hospital, Southern Medical University
Nanfang Hospital, Southern Medical University
Mansoura University
National Cancer Institute (NCI)